Europe — EMA
Ivabradín Teva Slovakia
GNH USA supplies Ivabradín Teva Slovakia (Ivabradine), an If channel inhibitor for chronic stable angina and heart failure with reduced ejection fraction.
Request sourcing
What is Ivabradine?
Ivabradine, the active ingredient in Ivabradín Teva Slovakia, is an If channel inhibitor presented as an oral dosage form for oral use. It is used to lower heart rate in patients with chronic stable angina pectoris and in heart failure with reduced ejection fraction.
GNH USA supplies Ivabradín Teva Slovakia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Ivabradine used for?
Ivabradine is used to manage cardiac conditions that benefit from selective heart‑rate reduction.
Chronic stable angina pectoris: reduces the frequency of angina attacks and improves exercise tolerance. Heart failure with reduced ejection fraction: lowers resting heart rate, helping to alleviate symptoms and decrease hospitalization risk. Elevated resting heart rate in coronary artery disease: helps control heart rate when beta‑blockers are not tolerated.
What are the side effects of Ivabradine?
Adverse reactions may occur with ivabradine therapy.
Common Side Effects: - Visual disturbances (phosphenes) - Headache - Dizziness - Fatigue - Nausea
Serious or Rare Side Effects: - Severe bradycardia - Atrial fibrillation - Symptomatic hypotension - Visual loss - Elevated liver enzymes
What precautions apply to Ivabradine?
Use ivabradine with careful clinical monitoring.
Monitor heart rate: ensure resting heart rate remains above the recommended minimum. Avoid in severe hepatic impairment: reduced metabolism may increase exposure. Caution with sick‑sinus syndrome: risk of excessive bradycardia. Do not combine with other strong heart‑rate‑lowering agents without supervision. Store below 25°C: keep in the original pack, protect from moisture.
What does Ivabradine interact with?
Ivabradine may interact with several medicines.
Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) - Concomitant use with other heart‑rate‑lowering drugs (beta‑blockers, digoxin) - Calcium‑channel blockers that inhibit CYP3A4 (verapamil, diltiazem)
Moderate Interactions (Monitor Closely): - Moderate CYP3A4 inhibitors (fluconazole, erythromycin) - CYP3A4 inducers (rifampicin, carbamazepine) may reduce efficacy - Antacids or agents that alter gastric pH may affect absorption
Frequently asked questions
What conditions is Ivabradín Teva Slovakia used for?+
How does ivabradine work to lower heart rate?+
What is the usual dose of Ivabradín Teva Slovakia?+
Is ivabradine safe during pregnancy or breastfeeding?+
How do I order Ivabradín Teva Slovakia from GNH USA?+
How does ivabradine compare with beta‑blockers?+
What are the recommended storage conditions for Ivabradín Teva Slovakia?+
How is Ivabradín Teva Slovakia administered?+
What are the most serious risks associated with ivabradine?+
Who should not use ivabradine?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo